Research analysts at William Blair lowered their Q2 2026 earnings estimates for J.Jill in a report released on Thursday, ...
Stock analysts at William Blair issued their FY2026 earnings per share estimates for shares of LENZ Therapeutics in a ...
The Wood County Commission plans to purchase half a dozen ambulances to assist WVU Medicine Camden Clark Medical Center in ...
The Wood County Commission plans to purchase half a dozen ambulances to assist WVU Medicine Camden Clark Medical Center in ...
1d
Fintel on MSNWilliam Blair Downgrades Valmont Industries (VMI)Fintel reports that on March 21, 2025, William Blair downgraded their outlook for Valmont Industries (NYSE:VMI) from ...
Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...
In a report released today, Andy Hsieh from William Blair maintained a Hold rating on BioAge Labs, Inc. (BIOA – Research Report). The company’s ...
As Klarna wins installment lending for the retail giant's OnePay app, rival Affirm seeks to downplay the loss.
We recently published a list of 10 Worst High-Risk High-Reward Growth Stocks To Buy. In this article, we are going to take a ...
Emerging markets present a landscape of opportunity for equity investors despite macroeconomic headwinds. Click to read.
So while NCAA Tournament teams began preparing for their first-round opponents on Sunday night, Texas won't know who it is ...
Overall, Palantir has had a solid start to 2025. Its growth numbers look impressive, and its AI platform is gaining traction across industries. Yet not everyone is convinced. Some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results